Gastrointestinal Drugs Market Report

Global Gastrointestinal Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：195
  • REPORT CODE：GMM873323
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

    Gastrointestinal Drugs market report explains the definition, types, applications, major countries, and major players of the Gastrointestinal Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • AstraZeneca

    • Bayer

    • Perrigo

    • Boehringer Ingelheim

    • Xian-Janssen

    • Abbott

    • Jiangzhong

    • Purdue Pharma

    • Sanofi

    • Pfizer

    • GlaxoSmithKline

    • Teva

    By Type:

    • Prescription Gastrointestinal Drug

    • OTC Gastrointestinal Drug

    By End-User:

    • Chronic Gastritis

    • Functional Dyspepsia

    • Peptic Ulcer

    • Acute Gastroenteritis

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Gastrointestinal Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Gastrointestinal Drugs Outlook to 2028- Original Forecasts

    • 2.2 Gastrointestinal Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Gastrointestinal Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Gastrointestinal Drugs Market- Recent Developments

    • 6.1 Gastrointestinal Drugs Market News and Developments

    • 6.2 Gastrointestinal Drugs Market Deals Landscape

    7 Gastrointestinal Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Gastrointestinal Drugs Key Raw Materials

    • 7.2 Gastrointestinal Drugs Price Trend of Key Raw Materials

    • 7.3 Gastrointestinal Drugs Key Suppliers of Raw Materials

    • 7.4 Gastrointestinal Drugs Market Concentration Rate of Raw Materials

    • 7.5 Gastrointestinal Drugs Cost Structure Analysis

      • 7.5.1 Gastrointestinal Drugs Raw Materials Analysis

      • 7.5.2 Gastrointestinal Drugs Labor Cost Analysis

      • 7.5.3 Gastrointestinal Drugs Manufacturing Expenses Analysis

    8 Global Gastrointestinal Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Gastrointestinal Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Gastrointestinal Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Gastrointestinal Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastrointestinal Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Prescription Gastrointestinal Drug Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global OTC Gastrointestinal Drug Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastrointestinal Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Chronic Gastritis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Functional Dyspepsia Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Peptic Ulcer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Acute Gastroenteritis Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Gastrointestinal Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Gastrointestinal Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Gastrointestinal Drugs Consumption (2017-2022)

      • 10.2.2 Canada Gastrointestinal Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Gastrointestinal Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.2 UK Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.3 Spain Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.5 France Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.6 Italy Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.8 Finland Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.9 Norway Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.11 Poland Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.12 Russia Gastrointestinal Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Gastrointestinal Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.2 Japan Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.3 India Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Gastrointestinal Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Gastrointestinal Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Gastrointestinal Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Gastrointestinal Drugs Consumption (2017-2022)

      • 10.5.3 Chile Gastrointestinal Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Gastrointestinal Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Gastrointestinal Drugs Consumption (2017-2022)

      • 10.5.6 Peru Gastrointestinal Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Gastrointestinal Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Gastrointestinal Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Gastrointestinal Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Gastrointestinal Drugs Consumption (2017-2022)

      • 10.6.3 Oman Gastrointestinal Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Gastrointestinal Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Gastrointestinal Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Gastrointestinal Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Gastrointestinal Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Gastrointestinal Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Gastrointestinal Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Gastrointestinal Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Gastrointestinal Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Gastrointestinal Drugs Consumption (2017-2022)

    11 Global Gastrointestinal Drugs Competitive Analysis

    • 11.1 AstraZeneca

      • 11.1.1 AstraZeneca Company Details

      • 11.1.2 AstraZeneca Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 AstraZeneca Gastrointestinal Drugs Main Business and Markets Served

      • 11.1.4 AstraZeneca Gastrointestinal Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Bayer

      • 11.2.1 Bayer Company Details

      • 11.2.2 Bayer Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Bayer Gastrointestinal Drugs Main Business and Markets Served

      • 11.2.4 Bayer Gastrointestinal Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Perrigo

      • 11.3.1 Perrigo Company Details

      • 11.3.2 Perrigo Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Perrigo Gastrointestinal Drugs Main Business and Markets Served

      • 11.3.4 Perrigo Gastrointestinal Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Boehringer Ingelheim

      • 11.4.1 Boehringer Ingelheim Company Details

      • 11.4.2 Boehringer Ingelheim Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Boehringer Ingelheim Gastrointestinal Drugs Main Business and Markets Served

      • 11.4.4 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Xian-Janssen

      • 11.5.1 Xian-Janssen Company Details

      • 11.5.2 Xian-Janssen Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Xian-Janssen Gastrointestinal Drugs Main Business and Markets Served

      • 11.5.4 Xian-Janssen Gastrointestinal Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Abbott

      • 11.6.1 Abbott Company Details

      • 11.6.2 Abbott Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Abbott Gastrointestinal Drugs Main Business and Markets Served

      • 11.6.4 Abbott Gastrointestinal Drugs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Jiangzhong

      • 11.7.1 Jiangzhong Company Details

      • 11.7.2 Jiangzhong Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Jiangzhong Gastrointestinal Drugs Main Business and Markets Served

      • 11.7.4 Jiangzhong Gastrointestinal Drugs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Purdue Pharma

      • 11.8.1 Purdue Pharma Company Details

      • 11.8.2 Purdue Pharma Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Purdue Pharma Gastrointestinal Drugs Main Business and Markets Served

      • 11.8.4 Purdue Pharma Gastrointestinal Drugs Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Sanofi

      • 11.9.1 Sanofi Company Details

      • 11.9.2 Sanofi Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Sanofi Gastrointestinal Drugs Main Business and Markets Served

      • 11.9.4 Sanofi Gastrointestinal Drugs Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Pfizer

      • 11.10.1 Pfizer Company Details

      • 11.10.2 Pfizer Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Pfizer Gastrointestinal Drugs Main Business and Markets Served

      • 11.10.4 Pfizer Gastrointestinal Drugs Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 GlaxoSmithKline

      • 11.11.1 GlaxoSmithKline Company Details

      • 11.11.2 GlaxoSmithKline Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 GlaxoSmithKline Gastrointestinal Drugs Main Business and Markets Served

      • 11.11.4 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Teva

      • 11.12.1 Teva Company Details

      • 11.12.2 Teva Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Teva Gastrointestinal Drugs Main Business and Markets Served

      • 11.12.4 Teva Gastrointestinal Drugs Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Gastrointestinal Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Gastrointestinal Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Prescription Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global OTC Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Gastrointestinal Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Chronic Gastritis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Functional Dyspepsia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Peptic Ulcer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Acute Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Gastrointestinal Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Gastrointestinal Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Gastrointestinal Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Gastrointestinal Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Gastrointestinal Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Gastrointestinal Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Gastrointestinal Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Gastrointestinal Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Gastrointestinal Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Gastrointestinal Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Gastrointestinal Drugs

    • Figure of Gastrointestinal Drugs Picture

    • Table Global Gastrointestinal Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Gastrointestinal Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Prescription Gastrointestinal Drug Consumption and Growth Rate (2017-2022)

    • Figure Global OTC Gastrointestinal Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Gastritis Consumption and Growth Rate (2017-2022)

    • Figure Global Functional Dyspepsia Consumption and Growth Rate (2017-2022)

    • Figure Global Peptic Ulcer Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Gastroenteritis Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Table North America Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Figure United States Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Figure Germany Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Figure China Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Figure Brazil Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Gastrointestinal Drugs Consumption by Country (2017-2022)

    • Figure Australia Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Gastrointestinal Drugs Consumption and Growth Rate (2017-2022)

    • Table AstraZeneca Company Details

    • Table AstraZeneca Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Gastrointestinal Drugs Main Business and Markets Served

    • Table AstraZeneca Gastrointestinal Drugs Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Gastrointestinal Drugs Main Business and Markets Served

    • Table Bayer Gastrointestinal Drugs Product Portfolio

    • Table Perrigo Company Details

    • Table Perrigo Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perrigo Gastrointestinal Drugs Main Business and Markets Served

    • Table Perrigo Gastrointestinal Drugs Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Gastrointestinal Drugs Main Business and Markets Served

    • Table Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio

    • Table Xian-Janssen Company Details

    • Table Xian-Janssen Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xian-Janssen Gastrointestinal Drugs Main Business and Markets Served

    • Table Xian-Janssen Gastrointestinal Drugs Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Gastrointestinal Drugs Main Business and Markets Served

    • Table Abbott Gastrointestinal Drugs Product Portfolio

    • Table Jiangzhong Company Details

    • Table Jiangzhong Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangzhong Gastrointestinal Drugs Main Business and Markets Served

    • Table Jiangzhong Gastrointestinal Drugs Product Portfolio

    • Table Purdue Pharma Company Details

    • Table Purdue Pharma Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma Gastrointestinal Drugs Main Business and Markets Served

    • Table Purdue Pharma Gastrointestinal Drugs Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Gastrointestinal Drugs Main Business and Markets Served

    • Table Sanofi Gastrointestinal Drugs Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Gastrointestinal Drugs Main Business and Markets Served

    • Table Pfizer Gastrointestinal Drugs Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Gastrointestinal Drugs Main Business and Markets Served

    • Table GlaxoSmithKline Gastrointestinal Drugs Product Portfolio

    • Table Teva Company Details

    • Table Teva Gastrointestinal Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Gastrointestinal Drugs Main Business and Markets Served

    • Table Teva Gastrointestinal Drugs Product Portfolio

    • Figure Global Prescription Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global OTC Gastrointestinal Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Gastritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Functional Dyspepsia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Peptic Ulcer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Gastrointestinal Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Gastrointestinal Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US